Conceptio
›
acute-myeloid-leukemia
Topic
acute-myeloid-leukemia
Knowledge-graph topic
· documents ABOUT acute-myeloid-leukemia across the archive
438
Documents about acute-myeloid-leukemia
Documents about acute-myeloid-leukemia
Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
#863606
ClinicalTrials.gov
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
#878283
ClinicalTrials.gov
Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia
#290983
ClinicalTrials.gov
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
#881236
ClinicalTrials.gov
Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders
#906637
ClinicalTrials.gov
Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia
#841751
ClinicalTrials.gov
Phase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia
#979474
ClinicalTrials.gov
Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission
#845132
ClinicalTrials.gov
Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors
#860477
ClinicalTrials.gov
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
#806238
ClinicalTrials.gov
WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
#628584
ClinicalTrials.gov
CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)
#668834
ClinicalTrials.gov
Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia
#967840
ClinicalTrials.gov
Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer
#907609
ClinicalTrials.gov
Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
#849188
ClinicalTrials.gov
S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin
#893399
ClinicalTrials.gov
Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia
#918864
ClinicalTrials.gov
Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML
#875244
ClinicalTrials.gov
Sunitinib in Treating Patients With Idiopathic Myelofibrosis
#885647
ClinicalTrials.gov
MS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
#917986
ClinicalTrials.gov
Natural Killer Cells in Older Patients With Acute Myeloid Leukemia
#825606
ClinicalTrials.gov
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
#908953
ClinicalTrials.gov
Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia</p>
#837065
ClinicalTrials.gov
Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
#908943
ClinicalTrials.gov
Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia
#873797
ClinicalTrials.gov
Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients
#813515
ClinicalTrials.gov
Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant
#407722
ClinicalTrials.gov
Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
#859618
ClinicalTrials.gov
Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720
#891740
ClinicalTrials.gov
VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia
#842965
ClinicalTrials.gov
Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)
#855452
ClinicalTrials.gov
Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia
#878690
ClinicalTrials.gov
A Dose Finding Study of IDH305 With Standard of Care in IDH1 Mutant Acute Myeloid Leukemia
#895578
ClinicalTrials.gov
Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia
#861849
ClinicalTrials.gov
Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML
#900843
ClinicalTrials.gov
Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
#870893
ClinicalTrials.gov
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
#871866
ClinicalTrials.gov
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
#918113
ClinicalTrials.gov
MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia
#911707
ClinicalTrials.gov
R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia
#894339
ClinicalTrials.gov
Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia
#874072
ClinicalTrials.gov
Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
#845912
ClinicalTrials.gov
Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes
#883841
ClinicalTrials.gov
Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
#811836
ClinicalTrials.gov
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
#836475
ClinicalTrials.gov
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
#866101
ClinicalTrials.gov
Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia
#874677
ClinicalTrials.gov
Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
#910204
ClinicalTrials.gov
Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia
#906153
ClinicalTrials.gov
NK Cell Infusion for Patients With Acute Myeloid Leukemia
#268074
ClinicalTrials.gov
← Previous
Page 2 of 18
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.